ArticleThe pharmacogenomics journal2018

The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.

T Magnes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.